世界の診断バイオマーカー市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Diagnostic Biomarkers Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4126 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、診断バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（安全性バイオマーカー、有効性バイオマーカー、検証バイオマーカー）、用途別市場規模（病院、がん研究所、診断研究所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・診断バイオマーカーの市場動向 ・企業の競争状況、市場シェア ・診断バイオマーカーの種類別市場規模と予測2016-2027（安全性バイオマーカー、有効性バイオマーカー、検証バイオマーカー） ・診断バイオマーカーの用途別市場規模と予測2016-2027（病院、がん研究所、診断研究所） ・診断バイオマーカーの北米市場規模2016-2027（アメリカ、カナダ） ・診断バイオマーカーの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・診断バイオマーカーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・診断バイオマーカーの中南米市場規模2016-2027（メキシコ、ブラジル） ・診断バイオマーカーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Qiagen N.V.、Perkinelmer, Inc.、Merck Millipore、Bio-Rad Laboratories, Inc.、Enzo Biochem, Inc.、EKF Diagnostics Holdings, Inc.、Meso Scale Diagnostics, LLC.、Biosims Technologies Sas、Cisbio Bioassays、Signosis, Inc、Banyan Biomarkers, Inc、Biomedical Corp） ・結論

Market Analysis and Insights: Global Diagnostic Biomarkers Market
The global Diagnostic Biomarkers market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diagnostic Biomarkers market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diagnostic Biomarkers market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diagnostic Biomarkers market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diagnostic Biomarkers market.

Global Diagnostic Biomarkers Scope and Market Size
Diagnostic Biomarkers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers

Segment by Application
Hospitals
Cancer Research Institutes
Diagnostic Labs

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Qiagen N.V.
Perkinelmer, Inc.
Merck Millipore
Bio-Rad Laboratories, Inc.
Enzo Biochem, Inc.
EKF Diagnostics Holdings, Inc.
Meso Scale Diagnostics, LLC.
Biosims Technologies Sas
Cisbio Bioassays
Signosis, Inc
Banyan Biomarkers, Inc
Biomedical Corp

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Biomarkers Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Safety Biomarkers
1.2.3 Efficacy Biomarkers
1.2.4 Validation Biomarkers
1.3 Market by Application
1.3.1 Global Diagnostic Biomarkers Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Cancer Research Institutes
1.3.4 Diagnostic Labs
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diagnostic Biomarkers Market Perspective (2016-2027)
2.2 Diagnostic Biomarkers Growth Trends by Regions
2.2.1 Diagnostic Biomarkers Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diagnostic Biomarkers Historic Market Share by Regions (2016-2021)
2.2.3 Diagnostic Biomarkers Forecasted Market Size by Regions (2022-2027)
2.3 Diagnostic Biomarkers Industry Dynamic
2.3.1 Diagnostic Biomarkers Market Trends
2.3.2 Diagnostic Biomarkers Market Drivers
2.3.3 Diagnostic Biomarkers Market Challenges
2.3.4 Diagnostic Biomarkers Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Biomarkers Players by Revenue
3.1.1 Global Top Diagnostic Biomarkers Players by Revenue (2016-2021)
3.1.2 Global Diagnostic Biomarkers Revenue Market Share by Players (2016-2021)
3.2 Global Diagnostic Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diagnostic Biomarkers Revenue
3.4 Global Diagnostic Biomarkers Market Concentration Ratio
3.4.1 Global Diagnostic Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Biomarkers Revenue in 2020
3.5 Diagnostic Biomarkers Key Players Head office and Area Served
3.6 Key Players Diagnostic Biomarkers Product Solution and Service
3.7 Date of Enter into Diagnostic Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diagnostic Biomarkers Breakdown Data by Type
4.1 Global Diagnostic Biomarkers Historic Market Size by Type (2016-2021)
4.2 Global Diagnostic Biomarkers Forecasted Market Size by Type (2022-2027)

5 Diagnostic Biomarkers Breakdown Data by Application
5.1 Global Diagnostic Biomarkers Historic Market Size by Application (2016-2021)
5.2 Global Diagnostic Biomarkers Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diagnostic Biomarkers Market Size (2016-2027)
6.2 North America Diagnostic Biomarkers Market Size by Type
6.2.1 North America Diagnostic Biomarkers Market Size by Type (2016-2021)
6.2.2 North America Diagnostic Biomarkers Market Size by Type (2022-2027)
6.2.3 North America Diagnostic Biomarkers Market Size by Type (2016-2027)
6.3 North America Diagnostic Biomarkers Market Size by Application
6.3.1 North America Diagnostic Biomarkers Market Size by Application (2016-2021)
6.3.2 North America Diagnostic Biomarkers Market Size by Application (2022-2027)
6.3.3 North America Diagnostic Biomarkers Market Size by Application (2016-2027)
6.4 North America Diagnostic Biomarkers Market Size by Country
6.4.1 North America Diagnostic Biomarkers Market Size by Country (2016-2021)
6.4.2 North America Diagnostic Biomarkers Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Diagnostic Biomarkers Market Size (2016-2027)
7.2 Europe Diagnostic Biomarkers Market Size by Type
7.2.1 Europe Diagnostic Biomarkers Market Size by Type (2016-2021)
7.2.2 Europe Diagnostic Biomarkers Market Size by Type (2022-2027)
7.2.3 Europe Diagnostic Biomarkers Market Size by Type (2016-2027)
7.3 Europe Diagnostic Biomarkers Market Size by Application
7.3.1 Europe Diagnostic Biomarkers Market Size by Application (2016-2021)
7.3.2 Europe Diagnostic Biomarkers Market Size by Application (2022-2027)
7.3.3 Europe Diagnostic Biomarkers Market Size by Application (2016-2027)
7.4 Europe Diagnostic Biomarkers Market Size by Country
7.4.1 Europe Diagnostic Biomarkers Market Size by Country (2016-2021)
7.4.2 Europe Diagnostic Biomarkers Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Biomarkers Market Size (2016-2027)
8.2 Asia-Pacific Diagnostic Biomarkers Market Size by Type
8.2.1 Asia-Pacific Diagnostic Biomarkers Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diagnostic Biomarkers Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diagnostic Biomarkers Market Size by Type (2016-2027)
8.3 Asia-Pacific Diagnostic Biomarkers Market Size by Application
8.3.1 Asia-Pacific Diagnostic Biomarkers Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diagnostic Biomarkers Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diagnostic Biomarkers Market Size by Application (2016-2027)
8.4 Asia-Pacific Diagnostic Biomarkers Market Size by Region
8.4.1 Asia-Pacific Diagnostic Biomarkers Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diagnostic Biomarkers Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diagnostic Biomarkers Market Size (2016-2027)
9.2 Latin America Diagnostic Biomarkers Market Size by Type
9.2.1 Latin America Diagnostic Biomarkers Market Size by Type (2016-2021)
9.2.2 Latin America Diagnostic Biomarkers Market Size by Type (2022-2027)
9.2.3 Latin America Diagnostic Biomarkers Market Size by Type (2016-2027)
9.3 Latin America Diagnostic Biomarkers Market Size by Application
9.3.1 Latin America Diagnostic Biomarkers Market Size by Application (2016-2021)
9.3.2 Latin America Diagnostic Biomarkers Market Size by Application (2022-2027)
9.3.3 Latin America Diagnostic Biomarkers Market Size by Application (2016-2027)
9.4 Latin America Diagnostic Biomarkers Market Size by Country
9.4.1 Latin America Diagnostic Biomarkers Market Size by Country (2016-2021)
9.4.2 Latin America Diagnostic Biomarkers Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Biomarkers Market Size (2016-2027)
10.2 Middle East & Africa Diagnostic Biomarkers Market Size by Type
10.2.1 Middle East & Africa Diagnostic Biomarkers Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diagnostic Biomarkers Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diagnostic Biomarkers Market Size by Type (2016-2027)
10.3 Middle East & Africa Diagnostic Biomarkers Market Size by Application
10.3.1 Middle East & Africa Diagnostic Biomarkers Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diagnostic Biomarkers Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diagnostic Biomarkers Market Size by Application (2016-2027)
10.4 Middle East & Africa Diagnostic Biomarkers Market Size by Country
10.4.1 Middle East & Africa Diagnostic Biomarkers Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diagnostic Biomarkers Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Qiagen N.V.
11.1.1 Qiagen N.V. Company Details
11.1.2 Qiagen N.V. Business Overview
11.1.3 Qiagen N.V. Diagnostic Biomarkers Introduction
11.1.4 Qiagen N.V. Revenue in Diagnostic Biomarkers Business (2016-2021)
11.1.5 Qiagen N.V. Recent Development
11.2 Perkinelmer, Inc.
11.2.1 Perkinelmer, Inc. Company Details
11.2.2 Perkinelmer, Inc. Business Overview
11.2.3 Perkinelmer, Inc. Diagnostic Biomarkers Introduction
11.2.4 Perkinelmer, Inc. Revenue in Diagnostic Biomarkers Business (2016-2021)
11.2.5 Perkinelmer, Inc. Recent Development
11.3 Merck Millipore
11.3.1 Merck Millipore Company Details
11.3.2 Merck Millipore Business Overview
11.3.3 Merck Millipore Diagnostic Biomarkers Introduction
11.3.4 Merck Millipore Revenue in Diagnostic Biomarkers Business (2016-2021)
11.3.5 Merck Millipore Recent Development
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Bio-Rad Laboratories, Inc. Company Details
11.4.2 Bio-Rad Laboratories, Inc. Business Overview
11.4.3 Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Introduction
11.4.4 Bio-Rad Laboratories, Inc. Revenue in Diagnostic Biomarkers Business (2016-2021)
11.4.5 Bio-Rad Laboratories, Inc. Recent Development
11.5 Enzo Biochem, Inc.
11.5.1 Enzo Biochem, Inc. Company Details
11.5.2 Enzo Biochem, Inc. Business Overview
11.5.3 Enzo Biochem, Inc. Diagnostic Biomarkers Introduction
11.5.4 Enzo Biochem, Inc. Revenue in Diagnostic Biomarkers Business (2016-2021)
11.5.5 Enzo Biochem, Inc. Recent Development
11.6 EKF Diagnostics Holdings, Inc.
11.6.1 EKF Diagnostics Holdings, Inc. Company Details
11.6.2 EKF Diagnostics Holdings, Inc. Business Overview
11.6.3 EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Introduction
11.6.4 EKF Diagnostics Holdings, Inc. Revenue in Diagnostic Biomarkers Business (2016-2021)
11.6.5 EKF Diagnostics Holdings, Inc. Recent Development
11.7 Meso Scale Diagnostics, LLC.
11.7.1 Meso Scale Diagnostics, LLC. Company Details
11.7.2 Meso Scale Diagnostics, LLC. Business Overview
11.7.3 Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Introduction
11.7.4 Meso Scale Diagnostics, LLC. Revenue in Diagnostic Biomarkers Business (2016-2021)
11.7.5 Meso Scale Diagnostics, LLC. Recent Development
11.8 Biosims Technologies Sas
11.8.1 Biosims Technologies Sas Company Details
11.8.2 Biosims Technologies Sas Business Overview
11.8.3 Biosims Technologies Sas Diagnostic Biomarkers Introduction
11.8.4 Biosims Technologies Sas Revenue in Diagnostic Biomarkers Business (2016-2021)
11.8.5 Biosims Technologies Sas Recent Development
11.9 Cisbio Bioassays
11.9.1 Cisbio Bioassays Company Details
11.9.2 Cisbio Bioassays Business Overview
11.9.3 Cisbio Bioassays Diagnostic Biomarkers Introduction
11.9.4 Cisbio Bioassays Revenue in Diagnostic Biomarkers Business (2016-2021)
11.9.5 Cisbio Bioassays Recent Development
11.10 Signosis, Inc
11.10.1 Signosis, Inc Company Details
11.10.2 Signosis, Inc Business Overview
11.10.3 Signosis, Inc Diagnostic Biomarkers Introduction
11.10.4 Signosis, Inc Revenue in Diagnostic Biomarkers Business (2016-2021)
11.10.5 Signosis, Inc Recent Development
11.11 Banyan Biomarkers, Inc
11.11.1 Banyan Biomarkers, Inc Company Details
11.11.2 Banyan Biomarkers, Inc Business Overview
11.11.3 Banyan Biomarkers, Inc Diagnostic Biomarkers Introduction
11.11.4 Banyan Biomarkers, Inc Revenue in Diagnostic Biomarkers Business (2016-2021)
11.11.5 Banyan Biomarkers, Inc Recent Development
11.12 Biomedical Corp
11.12.1 Biomedical Corp Company Details
11.12.2 Biomedical Corp Business Overview
11.12.3 Biomedical Corp Diagnostic Biomarkers Introduction
11.12.4 Biomedical Corp Revenue in Diagnostic Biomarkers Business (2016-2021)
11.12.5 Biomedical Corp Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Diagnostic Biomarkers Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Safety Biomarkers
Table 3. Key Players of Efficacy Biomarkers
Table 4. Key Players of Validation Biomarkers
Table 5. Global Diagnostic Biomarkers Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Diagnostic Biomarkers Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Diagnostic Biomarkers Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Diagnostic Biomarkers Market Share by Regions (2016-2021)
Table 9. Global Diagnostic Biomarkers Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Diagnostic Biomarkers Market Share by Regions (2022-2027)
Table 11. Diagnostic Biomarkers Market Trends
Table 12. Diagnostic Biomarkers Market Drivers
Table 13. Diagnostic Biomarkers Market Challenges
Table 14. Diagnostic Biomarkers Market Restraints
Table 15. Global Diagnostic Biomarkers Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Diagnostic Biomarkers Market Share by Players (2016-2021)
Table 17. Global Top Diagnostic Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Biomarkers as of 2020)
Table 18. Ranking of Global Top Diagnostic Biomarkers Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Diagnostic Biomarkers Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Diagnostic Biomarkers Product Solution and Service
Table 22. Date of Enter into Diagnostic Biomarkers Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Diagnostic Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Diagnostic Biomarkers Revenue Market Share by Type (2016-2021)
Table 26. Global Diagnostic Biomarkers Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Diagnostic Biomarkers Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Diagnostic Biomarkers Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Diagnostic Biomarkers Revenue Market Share by Application (2016-2021)
Table 30. Global Diagnostic Biomarkers Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Diagnostic Biomarkers Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Diagnostic Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Diagnostic Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Diagnostic Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Diagnostic Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Diagnostic Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Diagnostic Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Diagnostic Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Diagnostic Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Diagnostic Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Diagnostic Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Diagnostic Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Diagnostic Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Diagnostic Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Diagnostic Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Diagnostic Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Diagnostic Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Diagnostic Biomarkers Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Diagnostic Biomarkers Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Diagnostic Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Diagnostic Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Diagnostic Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Diagnostic Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Diagnostic Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Diagnostic Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Diagnostic Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Diagnostic Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Diagnostic Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Diagnostic Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Diagnostic Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Diagnostic Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 62. Qiagen N.V. Company Details
Table 63. Qiagen N.V. Business Overview
Table 64. Qiagen N.V. Diagnostic Biomarkers Product
Table 65. Qiagen N.V. Revenue in Diagnostic Biomarkers Business (2016-2021) & (US$ Million)
Table 66. Qiagen N.V. Recent Development
Table 67. Perkinelmer, Inc. Company Details
Table 68. Perkinelmer, Inc. Business Overview
Table 69. Perkinelmer, Inc. Diagnostic Biomarkers Product
Table 70. Perkinelmer, Inc. Revenue in Diagnostic Biomarkers Business (2016-2021) & (US$ Million)
Table 71. Perkinelmer, Inc. Recent Development
Table 72. Merck Millipore Company Details
Table 73. Merck Millipore Business Overview
Table 74. Merck Millipore Diagnostic Biomarkers Product
Table 75. Merck Millipore Revenue in Diagnostic Biomarkers Business (2016-2021) & (US$ Million)
Table 76. Merck Millipore Recent Development
Table 77. Bio-Rad Laboratories, Inc. Company Details
Table 78. Bio-Rad Laboratories, Inc. Business Overview
Table 79. Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Product
Table 80. Bio-Rad Laboratories, Inc. Revenue in Diagnostic Biomarkers Business (2016-2021) & (US$ Million)
Table 81. Bio-Rad Laboratories, Inc. Recent Development
Table 82. Enzo Biochem, Inc. Company Details
Table 83. Enzo Biochem, Inc. Business Overview
Table 84. Enzo Biochem, Inc. Diagnostic Biomarkers Product
Table 85. Enzo Biochem, Inc. Revenue in Diagnostic Biomarkers Business (2016-2021) & (US$ Million)
Table 86. Enzo Biochem, Inc. Recent Development
Table 87. EKF Diagnostics Holdings, Inc. Company Details
Table 88. EKF Diagnostics Holdings, Inc. Business Overview
Table 89. EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Product
Table 90. EKF Diagnostics Holdings, Inc. Revenue in Diagnostic Biomarkers Business (2016-2021) & (US$ Million)
Table 91. EKF Diagnostics Holdings, Inc. Recent Development
Table 92. Meso Scale Diagnostics, LLC. Company Details
Table 93. Meso Scale Diagnostics, LLC. Business Overview
Table 94. Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Product
Table 95. Meso Scale Diagnostics, LLC. Revenue in Diagnostic Biomarkers Business (2016-2021) & (US$ Million)
Table 96. Meso Scale Diagnostics, LLC. Recent Development
Table 97. Biosims Technologies Sas Company Details
Table 98. Biosims Technologies Sas Business Overview
Table 99. Biosims Technologies Sas Revenue in Diagnostic Biomarkers Business (2016-2021) & (US$ Million)
Table 100. Biosims Technologies Sas Recent Development
Table 101. Cisbio Bioassays Company Details
Table 102. Cisbio Bioassays Business Overview
Table 103. Cisbio Bioassays Diagnostic Biomarkers Product
Table 104. Cisbio Bioassays Revenue in Diagnostic Biomarkers Business (2016-2021) & (US$ Million)
Table 105. Cisbio Bioassays Recent Development
Table 106. Signosis, Inc Company Details
Table 107. Signosis, Inc Business Overview
Table 108. Signosis, Inc Diagnostic Biomarkers Product
Table 109. Signosis, Inc Revenue in Diagnostic Biomarkers Business (2016-2021) & (US$ Million)
Table 110. Signosis, Inc Recent Development
Table 111. Banyan Biomarkers, Inc Company Details
Table 112. Banyan Biomarkers, Inc Business Overview
Table 113. Banyan Biomarkers, Inc Diagnostic Biomarkers Product
Table 114. Banyan Biomarkers, Inc Revenue in Diagnostic Biomarkers Business (2016-2021) & (US$ Million)
Table 115. Banyan Biomarkers, Inc Recent Development
Table 116. Biomedical Corp Company Details
Table 117. Biomedical Corp Business Overview
Table 118. Biomedical Corp Diagnostic Biomarkers Product
Table 119. Biomedical Corp Revenue in Diagnostic Biomarkers Business (2016-2021) & (US$ Million)
Table 120. Biomedical Corp Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diagnostic Biomarkers Market Share by Type: 2020 VS 2027
Figure 2. Safety Biomarkers Features
Figure 3. Efficacy Biomarkers Features
Figure 4. Validation Biomarkers Features
Figure 5. Global Diagnostic Biomarkers Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Cancer Research Institutes Case Studies
Figure 8. Diagnostic Labs Case Studies
Figure 9. Diagnostic Biomarkers Report Years Considered
Figure 10. Global Diagnostic Biomarkers Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Diagnostic Biomarkers Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Diagnostic Biomarkers Market Share by Regions: 2020 VS 2027
Figure 13. Global Diagnostic Biomarkers Market Share by Regions (2022-2027)
Figure 14. Global Diagnostic Biomarkers Market Share by Players in 2020
Figure 15. Global Top Diagnostic Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Biomarkers as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Diagnostic Biomarkers Revenue in 2020
Figure 17. Global Diagnostic Biomarkers Revenue Market Share by Type (2016-2021)
Figure 18. Global Diagnostic Biomarkers Revenue Market Share by Type (2022-2027)
Figure 19. North America Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Diagnostic Biomarkers Market Share by Type (2016-2027)
Figure 21. North America Diagnostic Biomarkers Market Share by Application (2016-2027)
Figure 22. North America Diagnostic Biomarkers Market Share by Country (2016-2027)
Figure 23. United States Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Diagnostic Biomarkers Market Share by Type (2016-2027)
Figure 27. Europe Diagnostic Biomarkers Market Share by Application (2016-2027)
Figure 28. Europe Diagnostic Biomarkers Market Share by Country (2016-2027)
Figure 29. Germany Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Diagnostic Biomarkers Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Diagnostic Biomarkers Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Diagnostic Biomarkers Market Share by Region (2016-2027)
Figure 39. China Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Diagnostic Biomarkers Market Share by Type (2016-2027)
Figure 47. Latin America Diagnostic Biomarkers Market Share by Application (2016-2027)
Figure 48. Latin America Diagnostic Biomarkers Market Share by Country (2016-2027)
Figure 49. Mexico Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Diagnostic Biomarkers Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Diagnostic Biomarkers Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Diagnostic Biomarkers Market Share by Country (2016-2027)
Figure 55. Turkey Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Diagnostic Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Qiagen N.V. Revenue Growth Rate in Diagnostic Biomarkers Business (2016-2021)
Figure 59. Perkinelmer, Inc. Revenue Growth Rate in Diagnostic Biomarkers Business (2016-2021)
Figure 60. Merck Millipore Revenue Growth Rate in Diagnostic Biomarkers Business (2016-2021)
Figure 61. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Diagnostic Biomarkers Business (2016-2021)
Figure 62. Enzo Biochem, Inc. Revenue Growth Rate in Diagnostic Biomarkers Business (2016-2021)
Figure 63. EKF Diagnostics Holdings, Inc. Revenue Growth Rate in Diagnostic Biomarkers Business (2016-2021)
Figure 64. Meso Scale Diagnostics, LLC. Revenue Growth Rate in Diagnostic Biomarkers Business (2016-2021)
Figure 65. Biosims Technologies Sas Revenue Growth Rate in Diagnostic Biomarkers Business (2016-2021)
Figure 66. Cisbio Bioassays Revenue Growth Rate in Diagnostic Biomarkers Business (2016-2021)
Figure 67. Signosis, Inc Revenue Growth Rate in Diagnostic Biomarkers Business (2016-2021)
Figure 68. Banyan Biomarkers, Inc Revenue Growth Rate in Diagnostic Biomarkers Business (2016-2021)
Figure 69. Biomedical Corp Revenue Growth Rate in Diagnostic Biomarkers Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---